Here, definitely the presence and availability in the tumor microenvironment of sufficient amounts of key cytokines, such as IL-2 and IFNɣ produced by anti-tumor primed CD4+ T cells, facilitated the activation and function of CD8+ CTL effectors [41,42,43,48]. The gene discussed is IFNA1; the disease is neoplasm.